Washington Harbour Partners LP Purchases New Position in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Washington Harbour Partners LP acquired a new position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 161,300 shares of the company's stock, valued at approximately $1,744,000. Integral Ad Science makes up approximately 3.1% of Washington Harbour Partners LP's investment portfolio, making the stock its 17th largest holding. Washington Harbour Partners LP owned 0.10% of Integral Ad Science at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Integral Ad Science during the second quarter worth $4,724,000. Nisa Investment Advisors LLC raised its stake in shares of Integral Ad Science by 449,805.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company's stock worth $4,154,000 after purchasing an additional 427,315 shares in the last quarter. abrdn plc lifted its holdings in shares of Integral Ad Science by 12.5% during the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company's stock valued at $23,216,000 after buying an additional 237,930 shares during the last quarter. Invenomic Capital Management LP lifted its holdings in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company's stock valued at $6,327,000 after buying an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC bought a new stake in shares of Integral Ad Science in the 3rd quarter valued at approximately $1,795,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 10,481 shares of the business's stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now directly owns 239,709 shares of the company's stock, valued at $2,423,457.99. The trade was a 4.19 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Tania Secor sold 5,240 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the transaction, the chief financial officer now directly owns 248,223 shares of the company's stock, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 16,363 shares of company stock valued at $165,629. 2.00% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on IAS shares. Truist Financial cut their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Benchmark reissued a "hold" rating on shares of Integral Ad Science in a report on Thursday, November 14th. Piper Sandler decreased their target price on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating for the company in a research report on Wednesday, November 13th. Craig Hallum decreased their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Finally, Scotiabank assumed coverage on shares of Integral Ad Science in a report on Thursday. They issued a "sector perform" rating and a $10.00 target price on the stock. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $15.18.

Integral Ad Science Trading Up 0.7 %

Integral Ad Science stock traded up $0.08 during mid-day trading on Friday, hitting $10.94. The stock had a trading volume of 680,546 shares, compared to its average volume of 1,358,213. The stock has a market capitalization of $1.78 billion, a PE ratio of 54.30, a P/E/G ratio of 1.56 and a beta of 1.45. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $17.53. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock has a 50-day simple moving average of $11.11 and a two-hundred day simple moving average of $10.61.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million during the quarter, compared to analysts' expectations of $138.06 million. During the same period in the prior year, the business posted ($0.09) EPS. Integral Ad Science's revenue was up 11.0% on a year-over-year basis. As a group, sell-side analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.